These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21852549)

  • 1. Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2.
    Kurmann J; Sydler T; Brugnera E; Buergi E; Haessig M; Suter M; Sidler X
    Clin Vaccine Immunol; 2011 Oct; 18(10):1644-9. PubMed ID: 21852549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions.
    Seo HW; Han K; Oh Y; Park C; Chae C
    Vaccine; 2012 Oct; 30(47):6671-7. PubMed ID: 22963801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity.
    Fraile L; Grau-Roma L; Sarasola P; Sinovas N; Nofrarías M; López-Jimenez R; López-Soria S; Sibila M; Segalés J
    Vaccine; 2012 Mar; 30(11):1986-92. PubMed ID: 22245604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
    Seo HW; Han K; Park C; Chae C
    Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS).
    Pejsak Z; Podgórska K; Truszczyński M; Karbowiak P; Stadejek T
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e1-5. PubMed ID: 19910048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The index herd with PMWS in Sweden: presence of serum amyloid A, circovirus 2 viral load and antibody levels in healthy and PMWS-affected pigs.
    Wallgren P; Brunborg IM; Blomqvist G; Bergström G; Wikström F; Allan G; Fossum C; Jonassen CM
    Acta Vet Scand; 2009 Mar; 51(1):13. PubMed ID: 19327135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between porcine circovirus 2 antigen score and antibody titre and histology of lymph nodes in 375 euthanased sick and healthy pigs from 113 British pig farms with and without postweaning multisystemic wasting syndrome.
    Turner MJ; Medley GF; Woodbine KA; Slevin JA; Green LE
    Prev Vet Med; 2009 Mar; 88(3):213-9. PubMed ID: 19135273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms.
    Segalés J; Urniza A; Alegre A; Bru T; Crisci E; Nofrarías M; López-Soria S; Balasch M; Sibila M; Xu Z; Chu HJ; Fraile L; Plana-Duran J
    Vaccine; 2009 Dec; 27(52):7313-21. PubMed ID: 19800439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
    Kixmöller M; Ritzmann M; Eddicks M; Saalmüller A; Elbers K; Fachinger V
    Vaccine; 2008 Jun; 26(27-28):3443-51. PubMed ID: 18513842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets.
    Yang K; Li W; Niu H; Yan W; Liu X; Wang Y; Cheng S; Ku X; He Q
    Acta Vet Scand; 2012 Nov; 54(1):67. PubMed ID: 23171757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
    Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
    Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of porcine circovirus type 2 vaccination in reducing the severity of post-weaning multisystemic wasting syndrome in pigs.
    Velasova M; Alarcon P; Werling D; Nevel A; Wieland B
    Vet J; 2013 Sep; 197(3):842-7. PubMed ID: 23830301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2.
    Horlen KP; Dritz SS; Nietfeld JC; Henry SC; Hesse RA; Oberst R; Hays M; Anderson J; Rowland RR
    J Am Vet Med Assoc; 2008 Mar; 232(6):906-12. PubMed ID: 18341450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sow porcine circovirus type 2 (PCV2) status effect on litter mortality in postweaning multisystemic wasting syndrome (PMWS).
    Calsamiglia M; Fraile L; Espinal A; Cuxart A; Seminati C; Martín M; Mateu E; Domingo M; Segalés J
    Res Vet Sci; 2007 Jun; 82(3):299-304. PubMed ID: 17064740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
    Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease.
    Meerts P; Misinzo G; Lefebvre D; Nielsen J; Bøtner A; Kristensen CS; Nauwynck HJ
    BMC Vet Res; 2006 Jan; 2():6. PubMed ID: 16445856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a piglet-specific commercial inactivated vaccine against Porcine circovirus type 2 in clinical field trials.
    Han K; Seo HW; Oh Y; Park C; Kang I; Jang H; Chae C
    Can J Vet Res; 2013 Jul; 77(3):237-40. PubMed ID: 24101803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
    Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
    Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.